Pakistan’s power corridors are buzzing with controversy as PTI demands answers on Imran Khan’s latest eye treatment. The former PM’s Tuesday visit to PIMS for a second anti-VEGF injection has reignited debates on transparency and care quality under government watch.
Khan’s CRVO diagnosis surfaced end-January, with his debut procedure shrouded in delay—government confirmation came days later. Since then, salvos have flown: PTI blasts restricted access for personal medics and subpar oversight; officials counter with assurances of full compliance.
Inside PIMS, protocols were meticulous. Pre-procedure checks by a specialist team included cardiac evaluations via echo and ECG. The injection, targeting retinal issues, followed vitreo-retinal surgeon directives from PIMS and Al-Shifa in Rawalpindi. Stability marked every phase; discharge followed standard aftercare briefing.
PTI eyes Shifa International instead, citing trusted physicians there. Minister Chaudhry’s X clarification—secure PIMS transit, humanitarian adherence, March 24 third dose—only stoked PTI’s ire. Their response? A public callout: ditch secrecy for openness, or face more questions on hidden motives.
As this medical-political tangle unfolds, it mirrors Pakistan’s fractured landscape. Khan’s health narrative isn’t just personal—it’s a battleground for legitimacy, rights, and governance trust. Resolution demands not whispers, but clear, public accountability.